Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia
Open Access
- 27 November 2013
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 28 (6) , 1227-1234
Abstract
Mutations in the genetic sequence of the DNA de novo methyltransferase DNMT3A (DNA methyltransferase 3A) are found in many patients with acute myeloid leukemia (AML). They lead to dysfunction of DNMT3A protein and represent a marker for poor prognosis. Effects of genetic mutations can be mimicked by epigenetic modifications in the DNA methylation (DNAm) pattern. Using DNAm profiles of the Cancer Genome Atlas Research Network (TCGA), we identified aberrant hypermethylation at an internal promoter region of DNMT3A, which occurred in about 40% of AML patients. Bisulfite pyrosequencing assays designed for this genomic region validated hypermethylation specifically in a subset of our AML samples. High DNAm levels at this site are particularly observed in samples without genetic mutations in DNMT3A. Epimutations and mutations of DNMT3A were associated with related gene expression changes such as upregulation of the homeobox genes in HOXA and HOXB clusters. Furthermore, epimutations in DNMT3A were enriched in patients with poor or intermediate cytogenetic risk, and in patients with shorter event-free survival and overall survival (OS). Taken together, aberrant DNA hypermethylation within the DNMT3A gene, in analogy to DNMT3A mutations, is frequently observed in AML and both modifications seem to be useful for risk stratification or choice of therapeutic regimen.Keywords
This publication has 48 references indexed in Scilit:
- Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaBlood, 2013
- Interplay between the Cancer Genome and EpigenomeCell, 2013
- DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor bindingBlood, 2013
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging RatesMolecular Cell, 2013
- High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid LeukemiaPLOS ONE, 2012
- Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemiaLeukemia, 2012
- Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicingBlood, 2012
- Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancerHuman Molecular Genetics, 2012
- Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease SusceptibilityPLOS ONE, 2012
- Epimutation and cancer: A new carcinogenic mechanism of Lynch syndromeInternational Journal of Oncology, 2012